Aditxt, Inc. (ADTX)
0.716
-0.03
(-4.27%)
USD |
NASDAQ |
Jan 14, 12:25
Aditxt Research and Development Expense (Quarterly): 0.672M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pulmonx Corp. | 4.846M |
| Quantum-Si, Inc. | 13.88M |
| Perspective Therapeutics, Inc. | 19.56M |
| Electromed, Inc. | 0.241M |
| InfuSystem Holdings, Inc. | -- |